CD133, a member of the pentameric transmembrane glycoproteins, is considered the most important surface marker for the recognition of mesenchymal stem cells. CD133+ cells exhibit stem cell-like properties in a variety of tumors including glioma, colon cancer, pancreatic cancer, and liver cancer. This evidence concerns the gene PROM1 and glioma.